Your browser doesn't support javascript.
loading
Radiation Therapy for Primary Cutaneous Gamma Delta Lymphoma Prior to Stem Cell Transplantation.
Wu, Yufan F; Skinner, Lawrie; Lewis, Jonathan; Khodadoust, Michael S; Kim, Youn H; Kwong, Bernice Y; Weng, Wen-Kai; Hoppe, Richard T; Sodji, Quaovi; Hui, Caressa; Kastelowitz, Noah; Fernandez-Pol, Sebastian; Hiniker, Susan M.
Afiliação
  • Wu YF; Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA.
  • Skinner L; Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA.
  • Lewis J; Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA.
  • Khodadoust MS; Internal Medicine, Medical Oncology, Stanford University School of Medicine, Stanford, CA, USA.
  • Kim YH; Dermatology, Stanford University School of Medicine, Stanford, CA, USA.
  • Kwong BY; Dermatology, Stanford University School of Medicine, Stanford, CA, USA.
  • Weng WK; Stem Cell Transplantation, Stanford University School of Medicine, Stanford, CA, USA.
  • Hoppe RT; Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA.
  • Sodji Q; Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA.
  • Hui C; Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA.
  • Kastelowitz N; Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA.
  • Fernandez-Pol S; Pathology, Stanford University School of Medicine, Stanford, CA, USA.
  • Hiniker SM; School of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Cancer Invest ; : 1-8, 2023 Jan 31.
Article em En | MEDLINE | ID: mdl-33899635
ABSTRACT
We present a patient with widespread PCGD-TCL of the bilateral arms and legs, who underwent radiotherapy with 34 Gy in 17 fractions using circumferential VMAT and 3-D printed bolus to the four extremities prior to planned stem cell transplant, who was then found to have progression in the liver, lung, and skin, followed by drastic regression of all in and out-of-field lesions on imaging 1.5 months later. The cause of regression may be related to a radiation-induced abscopal effect from the immunomodulatory effects of radiation, or related to immune reactivation in the setting of cessation of systemic immunosuppressive agents.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancer Invest Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancer Invest Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos